Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 3
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis.
Nowak RJ, Benatar M, Ciafaloni E, Howard JF Jr, Leite MI, Utsugisawa K, Vissing J, Rojavin M, Li Q, Tang F, Wu Y, Rampal N, Cheng S; MINT Investigators. Nowak RJ, et al. N Engl J Med. 2025 Jun 19;392(23):2309-2320. doi: 10.1056/NEJMoa2501561. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202593 Clinical Trial.
Correction to: Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy.
Giossi R, Mercenari M, Filippi M, Zanetta C, Antozzi CG, Brambilla L, Confalonieri P, Crisafulli SG, Tomas Roldan E, Annovazzi P, Conti MZ, Barrilà C, Ronzoni M, Grobberio M, Negri A, Gustavsen S, Torri Clerici V. Giossi R, et al. Among authors: antozzi cg. J Neurol. 2024 Nov;271(11):7206-7207. doi: 10.1007/s00415-024-12560-5. J Neurol. 2024. PMID: 39251422 Free PMC article. No abstract available.
Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy.
Giossi R, Mercenari M, Filippi M, Zanetta C, Antozzi CG, Brambilla L, Confalonieri P, Crisafulli SG, Tomas Roldan E, Annovazzi P, Conti MZ, Barrilà C, Ronzoni M, Grobberio M, Negri A, Gustavsen S, Torri Clerici V. Giossi R, et al. Among authors: antozzi cg. J Neurol. 2024 Nov;271(11):7186-7205. doi: 10.1007/s00415-024-12472-4. Epub 2024 Jun 7. J Neurol. 2024. PMID: 38844694 Free PMC article.
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study.
Astrea G, Romano A, Angelini C, Antozzi CG, Barresi R, Battini R, Battisti C, Bertini E, Bruno C, Cassandrini D, Fanin M, Fattori F, Fiorillo C, Guerrini R, Maggi L, Mercuri E, Morani F, Mora M, Moro F, Pezzini I, Picillo E, Pinelli M, Politano L, Rubegni A, Sanseverino W, Savarese M, Striano P, Torella A, Trevisan CP, Trovato R, Zaraieva I, Muntoni F, Nigro V, D'Amico A, Santorelli FM; Italian CMD Network. Astrea G, et al. Among authors: antozzi cg. Orphanet J Rare Dis. 2018 Sep 26;13(1):170. doi: 10.1186/s13023-018-0863-x. Orphanet J Rare Dis. 2018. PMID: 30257713 Free PMC article.
Atypical Post-Injection Reactions with Delayed Onset Following Glatiramer Acetate 40 mg: Need for Titration?
Zecca C, Bellavia G, Brambilla L, Gutierrez LP, Gerardi C, Fiori AM, Bernardini LR, Camera G, Disanto G, Petrini L, Perugini J, Antozzi CG, Torri Clerici V, Bellino A, Confalonieri PA, Gobbi C, Mantegazza RE, Rossi S. Zecca C, et al. Among authors: antozzi cg. CNS Drugs. 2018 Jul;32(7):653-660. doi: 10.1007/s40263-018-0529-1. CNS Drugs. 2018. PMID: 29949101